# andrewprayle.github.io
Welcome to Andrew Prayle's github pages site.  On this site you will find links to the various evidence maps we have created.  

## Cystic Fibrosis Foundation and Cystic Fibrosis Trust commissioned evidence maps

The following evidence maps were commissioned as part of grants supporting the work of CochraneCF.

### Antibiotic Reviews:

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (status: evidence map completed and available online).  Click [here](/2024_pseudomonas_eradication_evidence_map.html) for the Pseudomonal eradication therapy evidence map.


Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis (status: review updated, no evidence map in preparation)


Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis (status: evidence map completed and available online).  Click [here](/2024_MRSA_evidence_map.html) for the MRSA evidence map.


Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis (status:review updated, no evidence map yet)


Macrolide antibiotics for cystic fibrosis (status: evidence map completed and available online).  Click [here](/2024_macrolide_evidence_map.html) for the macrolide evidence map.


### Infection prevention and control:

Infection prevention and control in cystic fibrosis
Click [here](/2024_Evidence_Map_Infection_Prevention_Control.html) to go to the interactive figure for Rowbotham, N. J., Smith, S., Jahnke, N., Milczanowski, S., Elliott, Z. C., Prayle, A. P., & Smyth, A. R. (2025). Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions. Journal of Cystic Fibrosis, 24(2), 359-363. https://doi.org/10.1016/j.jcf.2024.08.004

### NTM Reviews 

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis (status: review updated, no evidence map yet)

Non-antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis (status: review completed & submitted to BMJ Open Respiratory Research, evidence map in preparation)

Lung transplant in people with CF and NTM pulmonary disease (status: review almost completed, awaiting evidence map)

Institutional or domestic interventions to reduce water-borne transmission of nontuberculous mycobacteria (NTM) (status: review should be completed by mid-May, no evidence map yet)

## Original published evidence maps

Click [here](/interactive_figure.html) to go to the interactive figure from Prayle AP, Cox T, Smith SJ, et al. Do guidelines for treating chest disease in children use Cochrane Reviews effectively? A systematic review. Thorax. 2018;73:670-3.

Click [here](/gaps_review_figure.html) to go to the interactive figure from Rowbotham NJ, Smith S, Prayle AP, Robinson KA, Smyth AR. Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review. Thorax. 2019;74:229-36.






 




The current evidence map version is 0.053. 

